Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Amortization of Deferred Charges: 2022-2024

Historic Amortization of Deferred Charges for ADC Therapeutics (ADCT) over the last 3 years, with Dec 2024 value amounting to $902,000.

  • ADC Therapeutics' Amortization of Deferred Charges was N/A to $694,000 in Q4 2023 from the same period last year, while for Dec 2023 it was $3.0 million, marking a year-over-year change of. This contributed to the annual value of $902,000 for FY2024, which is 70.09% down from last year.
  • According to the latest figures from FY2024, ADC Therapeutics' Amortization of Deferred Charges is $902,000, which was down 70.09% from $3.0 million recorded in FY2023.
  • Over the past 5 years, ADC Therapeutics' Amortization of Deferred Charges peaked at $3.0 million during FY2023, and registered a low of $902,000 during FY2024.
  • For the 3-year period, ADC Therapeutics' Amortization of Deferred Charges averaged around $2.1 million, with its median value being $2.5 million (2022).
  • Its Amortization of Deferred Charges has fluctuated over the past 5 years, first rose by 20.88% in 2023, then slumped by 70.09% in 2024.
  • Over the past 3 years, ADC Therapeutics' Amortization of Deferred Charges (Yearly) stood at $2.5 million in 2022, then climbed by 20.88% to $3.0 million in 2023, then crashed by 70.09% to $902,000 in 2024.